© 2023 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
ADHD
ADHD medications do not significantly increase cardiovascular disease risk
January 16, 2023
A recent study found that the risk of cardiovascular diseases was not significantly greater in patients taking medications for attention-deficit/hyperactivity disorder (ADHD), but investigators were not able to rule out a mild risk increase.
Prenatal benzodiazepine exposure not directly associated with ASD and ADHD
January 11, 2023
A recent study found that while children exposed to benzodiazepine during pregnancy had a greater risk of developing autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD), siblings without exposure saw similar risks of neurodevelopmental disorders.
Lisdexamfetamine is effective in preschoolers with ADHD
December 27, 2022
Lisdexamfetamine dimesaylate was associated with reduced ADHD symptoms in children aged 4 to 5 years.
Final Thoughts on the Management of Pediatric ADHD
December 20, 2022
Robert L. Findling, MD, MBA; and Timothy Wilens, MD, share advice on the treatment of pediatric ADHD and new agents in the pipeline.
Safety and Efficacy of SDX/d-MPH in Pediatric ADHD
December 20, 2022
Drs Robert L. Findling and Timothy Wilens discuss the efficacy and safety data of serdexmethylphenidate/dexmethylphenidate (SDX/d-MPH) in childhood ADHD.
Role of SDX/d-MPH in Pediatric ADHD Treatment
December 20, 2022
Robert L. Findling, MD, MBA, and Timothy Wilens, MD, review serdexmethylphenidate-dexmethylphenidate, a combination agent recently approved for the treatment of ADHD.
Expert Perspectives on Novel Drug Delivery Systems in the Management of Pediatric ADHD
December 20, 2022
Jeffrey L. Alvaro, M.D., introduces an upcoming panel discussion surrounding the clinical implications of novel drug delivery systems in the management of Pediatric ADHD, utilizing 3 patient cases.
Drug Holidays and Challenges in Treatment Adherence in Pediatric ADHD
December 13, 2022
Robert L. Findling, MD, MBA, and Timothy Wilens, MD, consider the dosing and adherence challenges that arise in pediatric ADHD, as well as the potential benefits and damages of patients taking a break from treatment.
Treatment Dosage in Patients With Pediatric ADHD
December 13, 2022
Experts in psychiatry discuss strategies for titrating to optimal doses for patients with pediatric ADHD.
How white matter affects ADHD symptoms in children
December 06, 2022
MRI studies have associated white matter bundles with greater severity of ADHD symptoms.